# Evaluation of the GORE® Ascending Stent Graft

Study · id `cardio:ct-nct05800743` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05800743](<https://clinicaltrials.gov/study/NCT05800743>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05800743

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 370 participants.

## Technical summary

Registry record NCT05800743. Non-randomized; no masking; primary purpose treatment. Start 2023-11-28 (actual); primary completion 2029-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 370 participants (planned count; ClinicalTrials.gov record NCT05800743, source copy `cardio:ctgov-nct05800743-2026-05-29`, retrieved 2026-11-18)
- Started: 2023-11-28 (actual) (ClinicalTrials.gov record NCT05800743, source copy `cardio:ctgov-nct05800743-2026-05-29`, retrieved 2026-11-18)
- Primary completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT05800743, source copy `cardio:ctgov-nct05800743-2026-05-29`, retrieved 2026-11-18)
- Completion: 2034-01 (anticipated) (ClinicalTrials.gov record NCT05800743, source copy `cardio:ctgov-nct05800743-2026-05-29`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05800743, source copy `cardio:ctgov-nct05800743-2026-05-29`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05800743-2026-05-29`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of the GORE® Ascending Stent Graft
- Acronym: ARISEII
- Condition: Aortic Aneurysm, Thoracic
- Condition: Pseudoaneurysm
- Condition: Aortic Dissection
- Condition: Aorta; Lesion
- Intervention (Device): GORE® Ascending Stent Graft (ASG device)
- Intervention (Device): GORE® Thoracic Aortic Graft Thoracic Branch Endoprosthesis (TBE Device)
- Intervention (Procedure): Surgery
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: 6e1503a38f5a588a228f640dead0d8d9751d0844c02225ae467a2060a588467f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
